Syndax Pharmaceuticals. Every tracked FinTwit mention of $SNDX, newest first. 12 mentions since the first on Sep 8, 2025. See the price chart.
December 2025 · 4 mentions
Dec 8
Jacob Plieth — Interesting - $KURA reveals it's trying to get the Komzifti QTc prolongation warning removed $SNDX↗
Dec 6
Adam Feuerstein ✡️ — Hello! If you can break away from college football for a moment... #ASH25 Day One recap
$SNDX Revuforj frontline AML results
$VRTX $CRSP Casgevy in young kids
Star Therapeutics…↗
Dec 6
Adam Feuerstein ✡️ — $SNDX posted the Revuforj presentation on its web site https://t.co/KOz4CuIyfe↗
Dec 6
Adam Feuerstein ✡️ — I was in the $SNDX presentation. The Revuforj frontline combination AML data were very well received. #ASH25↗
November 2025 · 3 mentions
Nov 27
Jacob Plieth — If you need some biotech reading over Thanksgiving check out @ApexOnco previews of #ASH25 --> https://t.co/cqsR1AVbPH Starts in just over a week! $ACLX $ONC $CRVS $TERN $KURA $S…↗
Nov 13
Adam Feuerstein ✡️ — Kura Oncology $KURA secures approval for leukemia drug, its first https://t.co/auM9dGn08Y $SNDX↗
Nov 13
Adam Feuerstein ✡️ — $KURA Komzifti approved for r/r NPM1 mutated AML.
Here's the label: https://t.co/T0ZLLP4K1C
Black box safety warning for differentiation syndrome but not for QTc prolongation or…↗
October 2025 · 4 mentions
Oct 24
Adam Feuerstein ✡️ — @monaco_biotech I told you why $SNDX is down despite the approval. I'm not punishing a ticker.
Whether other drugs have black box warnings is irrelevant. What matters here is com…↗
Oct 24
Adam Feuerstein ✡️ — Following up: $SNDX closed -8% because the expanded Revuforj label now includes new black-box safety warnings for QTc prolongation and Torsades de Pointes.↗
Oct 24
Adam Feuerstein ✡️ — @PersimmonTI $SNDX I don't see an expanded label available yet, but the CR/CRh rate of 23% in the FDA release is lower than previously reported (26%)↗